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Purpose: To identify a technique that allows for comprehensive chromosome screening (CCS) of 28 
individual cells within the human blastocysts along with the approximation of their location in the 29 
trophectoderm relative to the inner cell mass.   This proof of concept study will allow for a greater 30 
understanding of chromosomal mosaicism at the blastocyst stage and the mechanisms by which 31 
mosaicism arises. 32 
Methods:  One blastocyst was held by a holding pipette and the inner cell mass was removed.  While 33 
still being held, the blastocyst was further biopsied into quadrants.  To separate the individual cells from 34 
the biopsied sections, the sections were placed in Calcium/Magnesium free medium with serum for 20 35 
minutes.  A holding pipette was used to aspirate the sections until individual cells were isolated.  36 
Individual cells from each section were placed into PCR tubes and prepped for array comparative 37 
genomic hybridization.  38 
Results:  A total of 18 cells were sent for analysis of which 15 (83.3%) amplified and provided a result 39 
and three (16.7%) did not.   40 
Fifteen cells were isolated from the trophectoderm, 13 (86.7%) provided an aCGH result while two 41 
(13.3%) did not amplify.  Twelve cells were euploid (46, XY) while one was complex abnormal (44, XY) 42 
presenting with monosomy 7, 10, 11, 13, 19 and trisomy 14, 15, 21. A total of three cells were isolated 43 
from the ICM, two were euploid (46, XY) and one did not amplify. 44 
Conclusion:  Here we expand on a previously published technique which disassociates biopsied sections 45 
of the blastocysts into individual cells.  Since the blastocyst sections were biopsied in regard to the 46 
position of the ICM, it was possible to reconstruct a virtual image of the blastocyst while presenting with 47 
each cell ?s individual CCS results. 48 
 49 
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Introduction 51 
 The presence of two or more distinct cell lines, commonly referred to as chromosomal 52 
mosaicism, is one of the potential pitfalls when analyzing embryos by comprehensive chromosome 53 
screening (CCS).  The ability to detect mosaicism accurately is determined by the technology used, 54 
number of chromosomes examined and number of cells analyzed (1).   Even if mosaicism is present, the 55 
impact on subsequent development varies depending upon which chromosome is involved and at what 56 
stage the chromosomal abnormality occurs (1). 57 
 CCS requires that the cells be pipetted into a PCR tube for analysis rather than fixed on a slide as 58 
previously performed with fluorescence in-situ hybridization (FISH) studies (2).  To examine individual 59 
cells, each cell needs to be pipetted individually into a PCR tube, and each tube must undergo the CCS 60 
procedure.  This makes the process labor intensive and expensive compared to FISH.   61 
 Although multiple studies have examined mosaicism at the blastocyst stage with CCS, these 62 
studies have all involved biopsied sections with multiple cells in each section, perhaps masking the true 63 
extent of mosaicism (3, 4, 5).  The examination of individual cells at the blastocyst stage is particularly 64 
important to gain insight into possible origins and mechanisms of mosaicism, such as non-disjunction, 65 
endoreduplication, anaphase lagging, uniparental disomy, and their prevalence during preimplantation 66 
development (1). Indeed, mosaicism could be responsible both for false negative and false positive PGS 67 
diagnoses (6, 7).  68 
In this present study, we expand upon a novel technique by which individual cells of a blastocyst 69 
could be isolated and a virtual image of the blastocyst with CCS results could be created (8).  70 
Unfortunately, the previous study did not perform CCS.  With this report, we have successfully isolated 71 
individual cells from the blastocyst, mapped their location in reference to the ICM, and successfully 72 
performed CCS on the individual cells.   This proof of concept study could allow insights into the 73 
mechanism through which mosaicism arose in the blastocyst.  74 
Methods 75 
 This study was approved by an institutional review board (WIRB #1138244) and utilized 76 
blastocysts deemed not viable and destined for discard.  The University of Kent Research Ethics Advisory 77 
Group also approved this study. 78 
  One blastocyst from a 33 year old patient, donated to research, that did not initially have 79 
assisted hatching, underwent the following procedure. The whole blastocyst was placed into a 20 µL 80 
drop of Calcium/Magnesium (Ca2+/Mg2+) free medium (Cooper/Sage, Trumbull, CT, USA) with 10% 81 
serum substitute supplement (SSS; Irvine Scientific, Santa Ana, California, USA) and overlayed by oil 82 
(Irvine Scientific, Santa Ana, California, USA).  The blastocyst was held with a holding pipette (Origio, 83 
ĞŶŵĂƌŬ ? ?ƉŽƐŝƚŝŽŶŝŶŐƚŚĞ/DĂƚƚŚĞ ?Ž ?ĐůŽĐŬƉŽƐŝƚŝŽŶ (Figure 1A).  A laser was used to create a hole in 84 
ƚŚĞƚƌŽƉŚĞĐƚŽĚĞƌŵĂƚƚŚĞ ?Ž ?ĐůŽĐŬƉŽƐŝƚŝŽŶ ?ďŝŽƉƐǇƉŝƉĞƚƚĞǁĂƐinserted into the blastocyst and the 85 
ICM was removed with gentle suction and isolated (Figure 1B).  The ICM was removed from the drop 86 
and placed into another drop of Ca2+/Mg2+ free with 10% SSS.  Using a similar method, Capalbo and 87 
colleagues (9) demonstrated a 2% trophectoderm contamination rate when removing the ICM.   88 
 The blastocyst underwent four further biopsies, thereby separating the blastocyst into 89 
quadrants (Figure 1C and Figure 1D).  After each biopsy, the biopsy needle was changed and the 90 
biopsied piece was pipetted out of the biopsy drop and into an individual drop of Ca2+/Mg2+ free 91 
medium + 10% SSS for 20 minutes (Figure 1E).  This process was repeated after each section so there 92 
was no cross contamination or mislabeling of sections during the procedure.  After 20 minutes, a holding 93 
pipette was used to gently aspirate the sections of the blastocysts (Figure 1F).  Doing so allowed the 94 
sections of the blastocyst to break apart into smaller pieces.  Therefore, multiple, individual cells were 95 
obtained from each quadrant (Figure 1G).   96 
 The cells of the blastocyst were identified under a dissecting scope.  Cells were rinsed in wash 97 
solution and prepped for aCGH.  aCGH was performed as previously described (10).  98 
  99 
Results 100 
A total of 18 cells were sent for aCGH.  Of the 15 cells isolated from the trophectoderm, 13 101 
(86.7%) provided a result while two (13.3%) did not amplify.  Twelve were euploid (46, XY) and one was 102 
complex abnormal (44, XY) presenting with monosomy 7, 10, 11, 13, 19 and trisomy 14, 15, 21.   The 103 
complex aneuploid cell ǁĂƐůŽĐĂƚĞĚŝŶƌĞŐŝŽŶ “ ? ?ǁŚŝĐŚŝƐĨƌŽŵƚŚĞƉŽůĂƌƚƌŽƉŚĞĐƚŽĚĞƌŵĂĚũĂĐĞŶƚƚŽƚŚĞ104 
ICM (Figure 2).   105 
A total of three cells were isolated from the ICM, 2 (66.7%) were euploid and one did not 106 
amplify (Figure 2).  107 
Discussion  108 
 We herein describe a novel approach that we believe to be the first to combine isolation of 109 
individual blastocyst cells with the utilization of CCS.  This powerful approach can be used to determine 110 
the extent of mosaicism in the human blastocyst.  Moreover, by examining the CCS results of individual 111 
cells within the blastocyst, the mechanisms of mosaicism can be determined (e.g.; non-disjunction, 112 
uniparental disomy, endoreduplication, or anaphase lagging) (1). 113 
 Multiple studies have attempted to determine mosaicism at the blastocyst stage with mosaicism 114 
rates ranging from 16-70% (11, 12, 13).  All three of these studies examined mosaicism in two to three 115 
sections of the trophectoderm, each containing several cells.  Examining these large of sections would 116 
not allow the chromosome constitution of individual cells within the blastocyst to be determined and 117 
thus, the true rate of mosaicism may be masked by the presence of multiple cells.  In order to minimize 118 
the impact of multiple cells on the rate of mosaicism, the chromosome results for individual cells must 119 
be examined. 120 
As previously mentioned, the detection of mosaicism is dependent upon on how many cells are 121 
analyzed.  All of these aforementioned studies examined mosaicism in these large sections which 122 
contained multiple cells.  In our study, our blastocyst was mosaic but this mosaicism would not have 123 
been detected had we not analyzed individual cells.  Eight individual aneuploidies were detected in the 124 
trophectoderm.  In a background of otherwise euploid cells we would infer that each was an individual 125 
post-zygotic error.  In the absence of a reciprocal pattern for each (i.e. a corresponding trisomy and 126 
monosomy of the same chromosome) we would infer that the +14, +15, +21 aneuploidies arose via 127 
independent chromosome gain (perhaps some mechanism involving endoreduplication) and the 128 
monosomies -7, -10, -11, -13, -19 by independent chromosome loss (anaphase lag).  Utilizing FISH, 129 
Delhanty and colleagues (14) and Ioannou and colleagues (15) demonstrated a lack of mitotic non-130 
disjunction (3+1 pattern), suggesting that mitotic non-disjunction is rare as a mechanism for post-zygotic 131 
aneuploidy in human development.   More recent data utilizing CCS supports the notion that non-132 
disjunction is a rare event, demonstrating that chromosome losses occur at 4x higher rate than 133 
chromosome gains (16).  WĞĚŝĚŶ ?ƚƚĞƐƚŝŶĚŝǀŝĚƵĂůĐĞůůƐĂŶĚƚŚĂƚŝƚ ?ƐƉŽƐƐŝďůĞǁĞ  “ŵŝƐƐĞĚ ?ƚŚĞ134 
corresponding reciprocal aneuploidies.  Further studies are certainly warranted to improve upon our 135 
technique.   136 
A meiotic error should be present in the entire, or at least a majority, of cells analyzed.  In our 137 
proof of concept study, only one cell contained aneuploidies while the remaining cells were euploid.  138 
This would suggest that the error arose during mitosis and not meiosis.  Previous research has 139 
demonstrated that approximately 25% of polar bodies are aneuploid (17) while approximately 50% of 140 
blastocysts are aneuploid (18, 19).  The higher incidence of aneuploidy at the blastocyst stage suggests 141 
that a majority of aneuploidy may be mitotic in origin.  The approach described in this study will allow us 142 
to test the hypothesis that post-zygotic aneuploidy of individual cells is commonplace in the trophoblast 143 
during human development but less so in the inner cell mass.  144 
Unfortunately, in our study we were only able to detect one aneuploidy cell.  It cannot be 145 
overlooked that our one aneuploid cell could be due to an error in the CCS test.  Capalbo and colleagues 146 
(20) demonstrated that aCGH overcalls aneuploidy.  However, Capalbo and colleagues (20) also 147 
demonstrated that on a per chromosome basis the accuracy of aCGH is >98%.  Another source of error 148 
ĐŽƵůĚďĞĚƵĞƚŽ “ŶŽŝƐĞ ?ǁŝƚŚŝŶƚŚĞƉůŽƚŽĨƚŚĞ^ƌĞƐƵůƚ ?^ŽŵĞE'^ƉƌŽƚŽĐŽůƐŵŝŶŝŵŝǌĞ “ŶŽŝƐĞ ? and 149 
produce cleaner CCS plots, reducing the chance of misdiagnosis.  NGS was not used in this study because 150 
it had not been validated on single cells when this study occurred, whereas aCGH had (21).  Moreover, 151 
Fiorentino and colleagues (22) reran 192 aCGH samples with NGS and found 191 (99.5%) were 152 
concordant.  Nonetheless, future studies should utilize NGS to reduce the chances of misdiagnosis.  Due 153 
to the high concordance of NGS to aCGH, the accuracy of aCGH on a per chromosome basis, and the fact 154 
that our study had eight different chromosomes from one cell diagnosed as aneuploidy, suggests that 155 
this aneuploid diagnosis is indeed biological and not an artifact.   156 
Ozawa and Hansen (23) were able to desegregate individual bovine blastocysts by exposure to 157 
trypsin and pipetting the blastocysts through a small glass pulled pipette.  Similarly, we utilized a holding 158 
pipette designed for holding the oocyte or embryo during micromanipulation procedures.  This pipette 159 
had a very small bore size and assisted in the separation of cells from the trophectoderm.  Our 160 
technique could also prove valuable for human embryonic stem cells (hESC).  Often times these cells are 161 
in clumps and clusters and the isolation of single hESC may be desired for hESC culture.  Prowse et al. 162 
(24) performed a similar process by which clumps of hESC were washed with Ca2+/Mg2+.  After the wash, 163 
they added trypsin to help in the dissociation of cells.  Similarly, Hasegawa and colleagues (25) also 164 
disassociated clumps of hESC into individual cells utilizing trypsin.  We did not add trypsin to our cells 165 
and it is unknown if this would have aided in our separation.  In these studies, trypsin was used on hESC 166 
whereas our study dealt with trophectoderm cells and trypsin may not separate trophectoderm cells as 167 
easily as hESC cells.  We utilized Ca/Mg free media because it was readily available and has been used in 168 
conjunction with CCS tests and embryo biopsy for years and its influence on CCS results would be 169 
minimal (26).  Another problem is the difficulty in the visualization of the cells after isolation.  One 170 
suggestion could be the addition of a hypotonic solution to the isolated cells, thereby allowing them to 171 
swell and become more easily distinguishable under a microscope (27).  Another technique referred to 172 
as optical tweezing allows for the control of small particles and possibly could be used to isolate 173 
individual cells (28,29).  However, this technique would require an expensive piece of equipment and 174 
training, neither of which our technique requires.   175 
Given our success with this proof of concept study, larger studies are certainly warranted, 176 
despite the cost of CCS.  Even increasing the number of blastocysts to 10 in our study would utilize 177 
approximately 200-250 CCS tests and patients may present with different rates of mosaicism thereby 178 
making a well-designed, high powered study difficult and costly.  Our findings stress the need to perform 179 
a similar study on a greater number of embryos with the ultimate aim of both improving diagnosis for 180 
PGS families and better understanding the nature of our own early development. 181 
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Figure 1: (A) The whole blastocyst with the quadrants and inner cell mass (ICM) marked prior to biopsy. 
(B) Blastocyst undergoing ICM removal, the quadrants are marked. (C) The blastocyst during the biopsy 
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Figure 2: Reconstructed trophectoderm and inner cell mass (ICM) with the location and the CCS results 
of individual cells within the blastocyst. 
 
 
 
 
 
